The NDA is supported by data from a clinical trial that compared the absorption and efficacy of the nasal treatment with oral and IV bumetanide in 68 healthy adults.
来自MSN6 个月
Researchers Developed A Nasal Spray That May Prevent Alzheimer's Disease By Clearing Tau ...“This nasal spray approach opens new avenues for non ... antibody named TTCM2 that can selectively identify and target tau accumulations. Then, they encapsulated TTCM2 in microscopic particles ...
"We are pleased the FDA has accepted our NDA for Bumetanide Nasal Spray," said Benjamin Esque, CEO of Corstasis Therapeutics ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈